BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 17, Issue 9
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews
©The Author(s) 2025.
World J Hepatol. Sep 27, 2025; 17(9): 107671
Published online Sep 27, 2025. doi: 10.4254/wjh.v17.i9.107671
Figure 2
Full Size Figure Download Figure
Figure 2 Glypican-3-mediated Wnt/β-catenin and YAP/TAZ signaling axes in hepatocellular carcinoma. GPC3 acts as a central signaling molecule that regulates two key pathways in hepatocellular carcinoma. One is the canonical Wnt/β-catenin pathway, where activated β-catenin translocates to the nucleus and induces the expression of oncogenic genes. The other is the alternative Wnt–YAP/TAZ pathway, in which activated YAP/TAZ translocate to the nucleus and promote tumor progression through transcriptional regulation. GPC3: Glypican-3.
Write to the Help Desk
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.